|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.20 USD | -0.49% |
|
-11.29% | -1.77% |
| 13/01 | Sarepta reconfirms yearly sales floor for Elevidys of $500.0 mln | RE |
| 13/01 | Sector Update: Health Care Stocks Lower in Afternoon Trading | MT |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | -.--% | -.--% | -4x | 1.99x | 1.38x | -7.96x | -7.01x | 223.3Cr | |
| -.--% | -.--% | -4.12x | 15.06x | 2.32x | -3.05x | -2.98x | 226.32Cr | |
| Average | 0% | 0% | -4.06x | 8.53x | 1.85x | -5.51x | -5.00x | 224.81Cr | |
| Weighted average by Cap. | 0% | 0% | -4.06x | 8.57x | 1.85x | -5.49x | -4.98x |
- Stock Market
- Equities
- SRPT Stock
- Sector Sarepta Therapeutics, Inc.
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition